LONDON, Sept 13 (Reuters) - Using OSI Pharmaceuticals Inc’s Tarceva pill to target tumours carrying specific genetic mutations significantly extended the lives of some people with lung cancer, Spanish researchers said on Saturday.
LONDON, Sept 13 (Reuters) - Using OSI Pharmaceuticals Inc’s Tarceva pill to target tumours carrying specific genetic mutations significantly extended the lives of some people with lung cancer, Spanish researchers said on Saturday.
